ICD-10-CM Diagnosis Code (2025)
Official Description for T80.8
Other complications following infusion, transfusion and therapeutic injection
Coding Notes & Guidelines for T80.8
- adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
- complication of bone marrow transplant (T86.0)
- complication of stem cell transplant (T86.5)
- code to identify the specific complication, such as:
- cytokine release syndrome (D89.83-)
- immune effector cell-associated neurotoxicity syndrome (G92.0-)
code to identify graft-versus-host reaction, if applicable, (D89.81-)
Infiltration of vesicant agent
Infiltration of vesicant antineoplastic chemotherapy
Infiltration of other vesicant agent
- Complication of chimeric antigen receptor (CAR-T) cell therapy
- Complication of IEC therapy
Delayed serologic transfusion reaction (DSTR), unspecified incompatibility
Parent Code (Less Specific):
About ICD-10-CM Code T80.8 (Other complications following infusion)
ICD-10-CM code T80.8 is a billable or specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM T80.8 became effective on October 1, 2024.
This page provides detailed information about T80.8 - Other complications following infusion, transfusion and therapeutic injection. It includes common terminology, coding guidelines such as "Includes," "Excludes1," and "Excludes2" notes, and information on required 7th characters. Utilizing this information correctly is essential for accurate medical coding and claims submission for conditions like Other complications following infusion related to transfusion and therapeutic injection.